Table 7.
Groups | IRS1 (pmol/g) | pIRS1 (pmol/g) | PI3K (pmol/g) | pPI3K (pmol/g) | PKB (nmol/g) | pPKB (nmol/g) |
---|---|---|---|---|---|---|
Control | 129.34 ± 24.84∗∗ | 55.11 ± 8.16∗∗ | 481.64 ± 59.49∗∗ | 35.51 ± 3.68∗∗ | 368.02 ± 38.53∗∗ | 161.01 ± 26.72∗∗ |
Model | 66.22 ± 13.00 | 28.21 ± 4.42 | 239.43 ± 44.41 | 16.76 ± 4.21 | 186.41 ± 29.58 | 83.35 ± 16.80 |
Salidroside | 97.63 ± 13.43∗∗ | 38.73 ± 5.22∗∗ | 328.04 ± 40.88∗∗ | 27.65 ± 3.62∗∗ | 280.31 ± 50.28∗∗ | 128.85 ± 10.50∗∗ |
Rosiglitazone | 88.12 ± 15.67∗ | 32.70 ± 5.31 | 271.35 ± 30.33# | 19.82 ± 3.69## | 210.72 ± 40.27## | 93.13 ± 12.62## |
∗∗ P < 0.01, ∗P < 0.05 versus model group; ##P < 0.01, #P < 0.05 versus salidroside group.